n CME : Your SA Journal of CPD - Pre-diabetes and the metabolic syndrome : more about

Volume 31, Issue 2
  • ISSN : 0256-2170



The American Diabetes Association (ADA) defines pre-diabetes as a fasting plasma glucose (FPG) ≥5.6 mmol/l but <7.0 mmol/l, which is termed impaired fasting glycaemia (IFG), or an abnormal 2-hour response to a 75 g oral glucose tolerance test (OGTT) of at least 7.8 mmol/l and <11.1 mmol/l, which is termed impaired glucose tolerance (IGT), or an HbA of 5.7 - 6.4%. It is used to identify individuals with a greater risk of developing overt type 2 diabetes and also those at increased cardiovascular risk. Pre-diabetes represents a continuum in the spectrum between normoglycaemia and overt hyperglycaemia.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error